Genmab AS Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

GMAB
Genmab AS

Last Price:

$19.38

Seasonality Move:

12.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Genmab AS Stock Forecast

Over the next 52 weeks, Genmab AS has on average historically risen by 41% based on the past 15 years of stock performance.
Genmab AS has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Genmab AS Stock Undervalued?

The current Genmab AS [GMAB] share price is $19.36. The Score for GMAB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

Over the next 52 weeks, Genmab AS has on average historically risen by 41% based on the past 15 years of stock performance.

Genmab AS Stock Rating

Sell

Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

Genmab AS has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Genmab AS Stock Price History

Is GMAB stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Denmark

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

genmab.com

52-Week Data

52-Week High:

30.41

52-Week Low:

17.24

Prediction Charts

Market Cap:

12B

Price in USD:

19.36

Volume:

2.2M

Beta:

0.71

Technical Analysis

SMA50:

20.31

SMA100:

20.57

SMA200:

22.54

52-Wk Change:

-32.8%

Stock Predictions

Is Genmab AS stock public?

Yes, Genmab AS is a publicly traded company.
What is the Genmab AS stock quote today?

The Genmab AS stock price is 19.36 USD today.
How to buy Genmab AS stock online?

You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	19.68	20.27	20.29	19.68
Apr-23	20.29	20.13	20.39	20.02
Apr-24	20.35	20.54	20.55	20.25
Apr-25	20.47	20.59	20.64	20.36
Apr-28	20.65	20.63	20.73	20.46
Apr-29	21.04	20.79	21.08	20.75
Apr-30	21.03	21.15	21.24	20.91
May-1	21.31	20.93	21.32	20.88
May-2	21.59	21.48	21.66	21.35
May-5	21.76	21.55	21.76	21.51
May-6	21.24	20.42	21.24	20.42
May-7	20.82	20.60	20.98	20.58
May-8	19.95	19.42	19.99	19.36
May-9	19.61	19.36	19.96	19.35

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $5.15 per share, an increase this year of $0.15 per share, and an increase next year of $0.40 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.